2Russi CR,Mocellin S,Pilati P,et al. Phannacokinetics of intrapefitoneal cisplatin and doxorubicin. Surg Oncol Clin N Am, 2003,12 (3) : 781 - 794.
3Glehen O,Stuart OA, Mohamed F, et al. Hyperthermia modifies pharmaeokinetics and tissue distribution of intraperitoneal melphalan in a rat model. Cancer Chemother Phannacol,2004,54( 1 ) :79 - 84.
4Van der Vange N,Van Goethem AR,Zoetmulder FA,et al. Extensive cytoreductive surgery combined with intra-operative intraperitoneal perfusion with cisplatin under hyperthennic conditions (OVHIPEC) in patients with recurrent ovarian cancer: a feasibility pilot. Eur J Surg Oncol,2000,26(7):663-668.
5Kobayashi K, Fujimoto S, Takahashi M, et al. A patient with stage Ⅲ c ovarian cancer with massive ascites who was chemotherapy resistant showed complete response with intrapefitoneal hyperthermic chemoperfusion. Gan To Kagaku Ryoho, 2003,30( 11 ) : 1726 - 1728.
6Chatzigeorgion K, Economou S,Chrysafis G, et al. Treatment of recurrent epithelial ovarian cancer with secondary cytoreduction and continuous intraoperative intraperitoneal hyperthermic chemoperfusion ( CIIPHCP). Zentralbl Gynakol,2003,125(10) :424 - 429.
7Ryu KS, Kim JH, Ko HS, et al. Effects of intrapefitoneal hyperthennic chemotherapy in ovarian cancer. Gynecol Oncol, 2004,94(2):325 - 332.
8Hager ED, Dziambor H, Hohmann D, et al. Intraperitoneal hyperthennic perfusion chemotherapy of patients with chemotherapy-resistant peritoneal disseminated ovarian cancer. Int J Gynecol Cancer,2001,11:57 - 63.
9Chatzigeorgion K, Economou S, Zafiriou G, et al. Continuous Intraoperative Intrapefitoneal Hyperthennic Chemoperfusion (CIIPHCP) in the treatment of advanced stage and recurrent granulosa cell tumors. Report of two cases. Zentralbl Gynakol,2002,124(7) :374 - 377.
10Deraco M, Rossi CR, Pennacchioli E, et al. Cytoreductive surgery followed by intrapefitoneal hyperthermic perfusion in the treatment of recurrent epithelial ovarian cancer:a phase Ⅱ clinical study.Tumori,2001,87(3) :120 - 126.
